Variable | Proportion or central measure |
---|---|
Population demographics and health status | |
Female n (%) | 432 (57%) |
Mean age (sd) | 33.9 (7.7) |
Nationality n (%) | |
 South African | 431 (57%) |
 Z¾±³¾²ú²¹²ú·É±ð²¹²Ô | 287 (38%) |
 Other African countries | 40 (5%) |
Marital status n (%) | |
 M²¹°ù°ù¾±±ð»å | 174 (24%) |
 Divorced or separate | 12 (2%) |
â€ÇȾ±²Ô²µ±ô±ð | 554 (75%) |
Employed n (%) | 551 (75%) |
Current alcohol use n (%) | 269 (36%) |
Current smoking n (%) | 116 (16%) |
WHO clinical stage | |
 I | 433 (59%) |
 I±õ | 164 (22%) |
 I±õI | 119 (16%) |
 I³Õ | 20 (3%) |
Median CD4 cells/μL at screening (IQR), nÌý=Ìý755a | 208 (118-299) |
Median plasma viral load copies/mL (IQR) | 64,782 (17,646–186,662) |
Laboratory screening tests prior to antiretroviral treatment | |
Creatinine clearance nÌý<Ìý50ÌýmL/min (%) | 4 (1%) |
Microalbumin-to-creatinine ratio mg/mmol n (%) | |
 3.4–33.9 | 40 (5%) |
 Ìý&²µ³Ù;Ìý34.0 | 2 (0%) |
Urine dipstick n (%) | |
 Proteinuria 1+ | 60 (8%) |
 Proteinuria 2+ | 14 (2%) |
 Proteinuria 3+ | 7 (1%) |
Hepatitis B surface antigen positive n (%) | 60 (8%) |
Abnormal ALT/AST IU/L n (%) in all patients | |
 40–99 (1-2.4 X normal) | 145 (19%) |
 100–199 (2.5-4.9 X normal) | 22 (3%) |
 Ìý≥Ìý200 (≥5 X normal) | 4 (1%) |
Abnormal ALT/AST IU/L n (%) If hepatitis B positive | |
 40–99 | 19 (32%) |
 100–199 | 2 (3%) |
 Ìý≥Ìý200 | 2 (3%) |
Anaemia in females n (%) | |
 8–10.0Ìý²µ/»å³¢ | 40 (9%) |
 Ìý&±ô³Ù;Ìý8.0Ìý²µ/»å³¢ | 10 (2%) |
Anaemia in males n (%) | Ìý |
 8–10.0Ìý²µ/»å³¢ | 13 (4%) |
 Ìý&±ô³Ù;Ìý8.0Ìý²µ/»å³¢ | 2 (1%) |
Neutrophil count | |
 Ìý<Ìý0.75Ìý×Ìý10^9 /L n (%) | 7 (1%) |
 Median cells (IQR) | 2.2 (1.6-2.9) |
Platelet counts (cells/μl) n (%) | |
 Ìý<Ìý50,000 | 3 (0) |
 50,000--125,000 | 25 (3) |